Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism (Q34323022)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism |
scientific article |
Statements
1 reference
Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism (English)
1 reference
Siegmund W
1 reference
Spieker K
1 reference
Weike AI
1 reference
Giessmann T
1 reference
Modess C
1 reference
Dabers T
1 reference
Kirsch G
1 reference
Sänger E
1 reference
Engel G
1 reference
Hamm AO
1 reference
Nauck M
1 reference
Meng W
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference